| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.00031 | 1 |